Incorporate into your daily practice the latest advances in hemostasis and antihemorrhagic agents from one of the world recognized experts in hematological research”

Scientific medical advances in the last 10 years have made it easier to change the notion that hematology is confined to mere hematometry, so this teaching program aims to focus the professional development of specialists in the many areas of the specialty (hematologic oncology, genetics, immunotherapy, cardiovascular risks, blood transfusions, bone marrow transplants, anticoagulants, anemias, artificial blood ....  ) so that excellent care is provided to hematology patients based on access to the most recent and innovative medical advances. 

The reasons why hematology and hemotherapy is one of the fastest progressing medical disciplines in terms of knowledge and technology in recent decades lie in the integration of biological and clinical knowledge, which has led to a better understanding of the mechanisms of disease, thereby facilitating the development of more appropriate guidelines for clinical action. All of this has contributed to hematology and hemotherapy reaching a remarkable degree of maturity and justifying its future as an integrated specialty, this being the ideal framework for specialization and improving specialists in this area of medical knowledge. 

This Postgraduate diploma in Advances in Anemias, Spinal Cord Disorders, Hemostasis Physiology and Antihemorrhagics endorses the latest advances in research and the highest scientific evidence, with a robust and didactic format program that positions it as a teaching product of the highest scientific rigor at international level, aimed at health professionals who in their daily clinical practice face a the care of patients or populations with hemorrhagic diseases. In addition, the program is based on a multidisciplinary approach to its subjects, which allows training and professional development in different areas. 

This Postgraduate diploma in Advances in Anemias, Spinal Cord Disorders, Hemostasis Physiology and Antihemorrhagics supports the latest advances in research and the highest scientific evidence, presenting a solid and didactic syllabus. In addition, it is enriched with a series of masterclasses given by a world eminence in hematology and hemotherapy, delving into the most impactful developments. The 100% online methodology of the program facilitates the achievement of the qualification for physicians with demanding responsibilities, as only a device with an Internet connection is needed, without the need to attend centers in person.

This Postgraduate diploma offers training in simulated environments, which provides an immersive learning experience designed to train for real” life situations"

This Postgraduate diploma in Advances in Anemias, Spinal Cord Disorders, Hemostasis Physiology and Antihemorrhagics contains the most complete and up-to-date scientific program on the market. The most important features of the specialization are:  

• Clinical symptoms cases presented by experts in hematology 
• The graphic, schematic, and eminently practical contents with which they are created provide scientific and practical information on the disciplines that are essential for professional 
• Diagnostictherapeutic developments on assessment, diagnosis, and treatment in hematology patients
• Practical exercises where the self-assessment process can be carried out to improve learning
• The Iconography of clinical and diagnostic imaging tests
• An algorithm-based interactive learning system for decision-making in the clinical situations presented throughout the course
• With special emphasis on evidence-based medicine and research methodologies in hematology
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any, fixed or portable device with an Internet connection

With the Postgraduate diploma in Advances in Anemias, Spinal Cord Disorders, Hemostasis Physiology and Antihemorrhagics, you have the opportunity to expand your knowledge comfortably and without sacrificing scientific accuracy, in order to incorporate the latest advances in the approach to infectious hematologic into your daily medical practice" 

The teaching body is made up of respected and renowned professionals with extensive experience in healthcare, teaching, and research, who have work in many countries where these diseases are prevalent. 

The methodological design of this Postgraduate diploma, developed by a multidisciplinary team of e-learning experts, integrates the latest advances in educational technology for the creation of numerous multimedia educational tools allow the professional, based primarily on the problem-based learning method, to address real problems in their daily clinical practice, which will allow them to advance by acquiring knowledge and developing skills that will impact their future professional work. 

It should be noted in this Postgraduate diploma that each of the contents generated, as well as the videos, self-evaluations, clinical cases and exams, have been thoroughly reviewed, updated, and integrated by the team of experts that make up the faculty, to ensure that the learning process is orderly and instructive in order to achieve the program's objectives. 

It includes clinical cases to bring the program's degree as close as possible to the reality of care in medicine"

The teaching program has been created by a group of professors and medical professionals from various specialties, with extensive medical, research, and teaching experience in several countries in Africa, Central and South America, interested in integrating the latest and most current scientific knowledge in hematology and hemotherapy to ensure training and professional development to improve the daily clinical practice of professionals. 

We have the most complete and up-to-date academic program in the market. We strive for excellence and for you to achieve it too" 

Module 1. Anemia Update 

1.1. Mechanism of Erythropoiesis, Erythroid Differentiation and Maturation

1.1.1. Biopathology and Physiopathology of Erythrocytes
1.1.2. Structure and Types of Hemoglobin
1.1.3. Functions of Hemoglobin

1.2. Classification of Erythrocyte Disorders and Clinical Manifestations

1.2.1. Classification of Erythrocyte Disorders
1.2.2. Symptoms and Signs of Anemia by Organ Systems

1.3. Pure Red Cell Aplasia

1.3.1. Concept
1.3.2. Etiology
1.3.3. Clinical Manifestations 
1.3.4. Diagnosis 
1.3.5. Current Treatment Alternatives

1.4. Congenital Dyserythropoietic Anemias

1.4.1. Concept
1.4.2. Etiology
1.4.3. Clinical Manifestations 
1.4.4. Diagnosis 
1.4.5. Current Treatments

1.5. Iron Deficiency Anemia and Alterations in Iron Metabolism and Iron Overload: Current Management

1.5.1. Concept
1.5.2. Classification and Etiology
1.5.3. Clinical Picture
1.5.4. Staged Diagnosis of Iron Disorders
1.5.5. Treatment Variants of Iron Disorders

1.6. Megaloblastic Anemias: Recent Advances

1.6.1. Concept
1.6.2. Classification and Etiology
1.6.3. Clinical Picture
1.6.4. Diagnostic Approach
1.6.5. Current Treatment Schemes and Recommendations

1.7. Hemolytic Anemias: From Laboratory to Clinic

1.7.1. Concept
1.7.2. Classification and Etiology
1.7.3. Clinical Picture
1.7.4. Diagnostic Challenges
1.7.5. Treatment Alternatives

1.8. Hemoglobin Disorder Anemias

1.8.1. Concept
1.8.2. Classification and Etiology
1.8.3. Clinical Picture
1.8.4. Analytical Diagnostic Challenges
1.8.5. Treatment Variants

Module 2. Scientific Developments in Spinal Cord Disorders 

2.1. Medullary Aplasia 

2.1.1. Definition.
2.1.2. Epidemiology and Etiology
2.1.3. Clinical Manifestations 
2.1.4. Clinical and Staged Diagnosis according to Diagnostic Tests
2.1.5. Latest Treatment Recommendations 

2.2. Myelodysplastic Syndromes: Latest Classifications

2.2.1. Definition
2.2.2. Epidemiology
2.2.3. Clinical Manifestations 
2.2.4. Diagnosis and Current Classifications
2.2.5. Current Review of the Treatment and Use of Hypomethylating Therapy

2.3. Updated Approach to Agranulocytosis

2.3.1. Definition
2.3.2. Epidemiology and Etiology
2.3.3. Clinical Manifestations 
2.3.4. Diagnostic Complexities
2.3.5. New Developments in Treatment

2.4. Polycythemia Vera 

2.4.1. Definition
2.4.2. Epidemiology
2.4.3. Clinical Manifestations
2.4.4. Diagnosis
2.4.5. Current Treatment Alternatives

2.5. Essential Thrombocythemia 

2.5.1. Definition
2.5.2. Epidemiology
2.5.3. Clinical Manifestations 
2.5.4. Diagnosis 
2.5.5. Treatment Review

2.6. Chronic Idiopathic Myelofibrosis

2.6.1. Definition
2.6.2. Epidemiology
2.6.3. Clinical Manifestations
2.6.4. Diagnosis 
2.6.5. Therapeutic Approaches

2.7. Hypereosinophilic Syndrome 

2.7.1. Definition
2.7.2. Epidemiology
2.7.3. Clinical Manifestations 
2.7.4. Diagnostic Complexities
2.7.5. Treatment: Literature Review 

2.8. Mastocytosis 

2.8.1. Definition
2.8.2. Epidemiology
2.8.3. Clinical Manifestations
2.8.4. Use of Diagnostic Tests 
2.8.5. Alternative Treatments 

Module 3. Current Events in Hemostasis Physiology 

3.1. Update on the Biopathology of Hemostasis Types

3.1.1. Primary Hemostasis
3.1.2. Secondary Hemostasis

3.2. Advances in Vascular Endothelium Biology and Functions

3.2.1. Vascular Endothelium Biology
3.2.2. Vascular Endothelium Functions
3.2.3. Main Vascular Endothelial Mediators
3.2.4. Endothelial Dysfunction

3.3. Platelets and their Role in Coagulation: Recent Discoveries 

3.3.1. Platelet Formation
3.3.2. Platelet Functions and Mediators
3.3.3. Platelets in Hemostasis

3.4. Plasma Factors and the Coagulation Cascade: From Research to the Clinic

3.4.1. Synthesis and Structure of Coagulation Factors
3.4.2. Functions of Plasma Coagulation Factors in the Coagulation Cascade
3.4.3. Coagulation Factor Deficiency

3.5. Cofactors Necessary for Blood Coagulation

3.5.1. Vitamin K and Coagulation
3.5.2. Prekallikrein
3.3.3. High Molecular Weight Cininogen
3.4.4. Von Willebrand Factor

3.6. Physiological Inhibitors of Coagulation

3.6.1. Antithrombin
3.6.2. Protein C-Protein S System
3.6.3. Antitrypsins
3.6.4. Antiplasmins
3.6.5. Other Coagulation Inhibitor Proteins

3.7. Current Events in Pregnancy and Hemostasis

3.7.1. Hemostasis Changes during Pregnancy
3.7.2. Fibrinolysis Changes during Pregnancy 

3.8. New Developments in Hemostasis in Hepatic Insufficiency and Renal Insufficiency

3.8.1. Acute Hepatic Insufficiency and Hemostatic Disorders
3.8.2. Chronic Hepatic Insufficiency and Hemostatic Disorders
3.8.3. Hemostasis in Chronic Kidney Disease
3.8.4. Hemostasis in Patients with Renal Function Replacement Treatment

Module 4. Update on Antihemorrhagics 

4.1. Antihemorrhagic Drugs 

4.1.1. Definitions
4.1.2. Main Drugs
4.1.3. Mechanism of Action
4.1.4. Main Indications

4.2. Use of Vitamin K in Hemorrhagic Disorders

4.2.1. Indication of Vitamin K in Hemorrhagic Disorders
4.2.2. Pharmacokinetics and Pharmacodynamics
4.2.3. Presentation and Dosage

4.3. Coagulation Factor Concentrate

4.3.1. Treatment Indications
4.3.2. Pharmacokinetics and Pharmacodynamics
4.3.3. Presentation and Dosage

4.4. Use of Fresh Frozen Plasma and Protamine Sulfate

4.4.1. Treatment Indications
4.4.2. Pharmacokinetics and Pharmacodynamics 
4.4.3. Presentation and Dosage

4.5. Latest Recommendations for the Use of Platelets

4.5.1. Treatment Indications
4.5.2. Pharmacokinetics and Pharmacodynamics
4.5.3. Presentation and Dosage

4.6. Platelet Aggregation Inhibitors: The Reality of Use

4.6.1. Treatment Indications
4.6.2. Pharmacokinetics and Pharmacodynamics
4.6.3. Presentation and Dosage

4.7. Capillary Protective and Hemostatic Vasoconstrictor Drugs

4.7.1. Treatment Indications
4.7.2. Pharmacokinetics and Pharmacodynamics
4.7.3. Presentation and Dosage

4.8. Antifibrinolytics 

4.8.1. Treatment Indications
4.8.2. Pharmacokinetics and Pharmacodynamics
4.8.3. Presentation and Dosage

A unique, key, and decisive master’s degree experience to boost your professional development”